BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11368376)

  • 1. Prognostic factors in acute myelogenous leukemia.
    Estey EH
    Leukemia; 2001 Apr; 15(4):670-2. PubMed ID: 11368376
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
    George DJ; Halabi S; Shepard TF; Vogelzang NJ; Hayes DF; Small EJ; Kantoff PW;
    Clin Cancer Res; 2001 Jul; 7(7):1932-6. PubMed ID: 11448906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts.
    Foss B; Mentzoni L; Bruserud O
    J Hematother Stem Cell Res; 2001 Feb; 10(1):81-93. PubMed ID: 11276362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor platelet counts, and prognosis in renal cancer.
    O'Byrne KJ; Dobbs N; Propper D; Smith K; Harris AL
    Lancet; 1999 May; 353(9163):1494-5. PubMed ID: 10232320
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
    Cortes J; Kantarjian H; Albitar M; Thomas D; Faderl S; Koller C; Garcia-Manero G; Giles F; Andreeff M; O'Brien S; Keating M; Estey E
    Cancer; 2003 Mar; 97(5):1234-41. PubMed ID: 12599230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of VEGF levels for ovarian hyperstimulation.
    Bussen S; Dietl J
    Fertil Steril; 2003 Sep; 80(3):681-2; author reply 682. PubMed ID: 12969739
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular endothelial growth factor platelet counts and renal cancer.
    Gunsilius E; Petzer AL; Gastl G
    Lancet; 1999 Jun; 353(9171):2247. PubMed ID: 10393017
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients.
    Hayashibara T; Fujimoto T; Miyanishi T; Yamada Y; Maita T; Kamihira S; Tomonaga M
    Leukemia; 1999 Oct; 13(10):1634-5. PubMed ID: 10516769
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia.
    Hefler L; Obermair A; Husslein P; Kainz C; Tempfer C
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):77-8. PubMed ID: 10646821
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum levels of vascular endothelial growth factor in chronic leukemias. A comparative study with emphasis on myeloproliferative disorders.
    Molica S; Santoro R; Iuliano F; Di Raimondo F; Fichera E; Giustolisi R
    Haematologica; 2001 Jul; 86(7):771. PubMed ID: 11454538
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiogenesis in B-chronic lymphocytic leukemia.
    Kay NE; Jelinek DF; Peterson L
    Leuk Res; 2001 Jun; 25(6):485-6. PubMed ID: 11337021
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients.
    O'Byrne KJ; Dobbs N; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1895-6. PubMed ID: 10839310
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular endothelial growth factor in prostate cancer.
    Turner K; Jones A
    Urology; 2000 Jul; 56(1):183. PubMed ID: 10939977
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma.
    Gunsilius E; Petzer AL; Gastl G
    Br J Haematol; 2000 Mar; 108(3):661-3. PubMed ID: 10847704
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
    Heeschen C; Dimmeler S; Hamm CW; Boersma E; Zeiher AM; Simoons ML;
    Circulation; 2003 Feb; 107(4):524-30. PubMed ID: 12566361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VEGF (vascular endothelial growth factor)].
    Hayashi K
    Nihon Rinsho; 1999 Nov; 57 Suppl():805-7. PubMed ID: 10635975
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.
    Kähler CM; Prior C; Gunsilius E
    Am J Respir Crit Care Med; 2001 Mar; 163(4):1030-1. PubMed ID: 11282785
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
    Brunner B; Gunsilius E; Schumacher P; Zwierzina H; Gastl G; Stauder R
    J Hematother Stem Cell Res; 2002 Feb; 11(1):119-25. PubMed ID: 11847008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma vascular endothelial growth factor levels in scleroderma are not correlated with disease activity.
    Viac J; Schmitt D; Claudy A
    Acta Derm Venereol; 2000; 80(5):383. PubMed ID: 11200843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.